Ocrelizumab slows hand function decline in multiple sclerosis patients
9 giờ trước
bởiJairia Dela Cruz
Treatment with ocrelizumab helps delay progression of disability, especially of the upper limb, in a broad population of patients with primary progressive multiple sclerosis (PPMS), including those who are older and have more advanced disease, according to the phase 3b ORATORIO-HAND trial.
